Cetuximab and Irinotecan
About
Membership operator: AND
Therapies: 2
Therapies
Cetuximab (tx:ncit:C1723)
Irinotecan (tx:ncit:C62040)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | EGFR positive, Wild type KRAS | Colorectal Adenocarcinoma | Cetuximab, Irinotecan | |
| EMA (1) | EGFR positive, Wild type HRAS, Wild type KRAS, Wild type NRAS | Colorectal Adenocarcinoma | Cetuximab, Irinotecan |